Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | HRH1 | P35367 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8045802 | 0.93 | HRH1 (0.50) | CYP2D6CYP2C9HRH1CYP3A4CYP1A2 | |
| SCHEMBL7445422 | 0.91 | HRH1 (0.58) | CYP2D6CYP2C9HRH1CYP3A4CYP1A2 | |
| SCHEMBL7449242 | 0.85 | HRH1 (0.61) | CYP2D6CYP2C9HRH1CYP3A4CYP1A2 | |
| SCHEMBL29582320 | 0.85 | HRH1 (0.60) | CYP2D6HRH1CYP1A2CYP2C19HRH3 | |
| SCHEMBL64052 | 0.85 | HRH1 (0.60) | CYP2D6HRH1CYP1A2CYP2C19HRH3 | |
| SCHEMBL29263687 | 0.84 | HRH1 (0.71) | CYP2D6CYP2C9HRH1CYP3A4CYP1A2 | |
| SCHEMBL7449958 | 0.84 | HRH1 (0.65) | CYP2D6CYP2C9HRH1CYP3A4CYP1A2 | |
| SCHEMBL7452998 | 0.84 | HRH1 (0.65) | CYP2D6CYP2C9HRH1CYP3A4CYP1A2 | |
| SCHEMBL7448741 | 0.84 | HRH1 (0.65) | CYP2D6CYP2C9HRH1CYP3A4CYP1A2 | |
| SCHEMBL1807177 | 0.84 | HRH1 (0.65) | CYP2D6CYP2C9HRH1CYP3A4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | disclosed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | CYP2D6 1353/4885CYP2C9 2683/4885HRH1 3579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.